Medtech Leaders Unite on Capitol Hill to Fight Tariffs

Medtech leaders unite on Capitol Hill to fight tariffs

The post Medtech leaders unite on Capitol Hill to fight tariffs appeared first on Medical Device Network.

Abbott and Medtronic best positioned manufacturers in US neurology market, says GlobalData

As US tariff policies evolve in 2025, neurology device manufacturers face rising cost pressures and growing uncertainty over production strategy. However, Abbott and Medtronic are best positioned among top competitors, with majority of their 510(k)-approved neurology devices manufactured exclusively in the US, respectively, according to the MedSource Database of GlobalData, a leading data and analytics company. GlobalData’s report, “Impact of US…

GlobalData highlights impact of US tariffs on medical robotics industry

The US government’s imposition of new tariffs in 2025 marks a significant shift in trade policy that has wide-reaching implications across multiple sectors, including healthcare. Among the most affected segments is the medical robotics industry, a high-growth field that blends precision engineering, artificial intelligence (AI), and life-saving applications in surgery and diagnostics. While tariffs are largely aimed at economic and geopolitical …